Astellas Pharma Inc.

ALPMF · OTC
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$188,372$335,687$376,840$315,986
Short-Term Investments$29,941$28,784$19,784$21,297
Receivables$632,525$534,985$427,965$382,462
Inventory$297,261$248,738$174,386$153,072
Other Curr. Assets$53,250$46,536$50,979$50,537
Total Curr. Assets$1,201,349$1,194,730$1,049,954$923,354
Property Plant & Equip (Net)$328,921$293,742$286,459$269,044
Goodwill$415,207$418,694$328,411$303,030
Intangibles$1,123,714$1,453,824$562,496$623,431
Long-Term Investments$172,239$144,421$90,791$141,206
Tax Assets$98,113$0$84,169$72,331
Other NC Assets$1$64,192$54,238-$1
Total NC Assets$2,138,195$2,374,873$1,406,564$1,409,041
Other Assets$0$0$0$0
Total Assets$3,339,544$3,569,603$2,456,518$2,332,395
Liabilities
Payables$187,840$185,193$140,236$130,739
Short-Term Debt$266,533$487,222$88,546$157,730
Tax Payable$34,549$38,515$5,137$32,388
Deferred Revenue$0$0-$88,546-$157,730
Other Curr. Liab.$572,688$574,795$580,661$524,284
Total Curr. Liab.$1,061,610$1,285,725$726,034$687,411
LT Debt$564,893$518,494$111,461$55,690
Deferred Rev, NC$0$70,756$121,279$138,943
Deferred Tax Liab, NC$5,353$51,346$6,048$5,823
Other NC Liab.$194,433$96,442$51,251$45,733
Total NC Liab.$764,679$687,890$222,530$184,676
Other Liabilities$0$0$0$0
Cap. Leases$0$85,700$75,007$72,744
Total Liabilities$1,826,289$1,973,615$948,564$872,087
Equity
Pref Stock$0$0$0$0
Common Stock$103,001$103,001$103,001$103,001
Retained Earnings$740,939$809,400$908,158$944,261
AOCI$521,580$533,300$340,639$247,512
Other Equity$147,735$150,287$156,157$165,533
Total Equity$1,513,255$1,595,988$1,507,954$1,460,308
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$3,339,544$3,569,603$2,456,518$2,332,395
Net Debt$643,054$670,029-$176,833-$102,566
Astellas Pharma Inc. (ALPMF) Financial Statements & Key Stats | AlphaPilot